The latest oncology treatment & supportive care news
A randomized phase III clinical trial showed that many people with advanced kidney cancer can…
A large, randomized phase III trial shows that the immunotherapy pembrolizumab (Keytruda®) is a more…
“This is one more example of how immunotherapy is making steady gains against a number…
In a phase III clinical trial, a new targeted medicine, taselisib, combined with standard hormone…
Glioblastoma multiforme, a type of brain tumour, is one of the most difficult-to-treat cancers. Only…
In a phase III clinical trial, a new targeted medicine, taselisib, combined with standard hormone…
To survive and thrive, tumours find a way of thwarting our body’s natural systems. By…
An analysis of pooled data from nine randomized phase III trials of more than 8,000…
In a prospective clinical trial of 100 men with metastatic castration-resistant prostate cancer, the response…
An analysis of cancer registry data from a California hospital system shows that women with…